Opportunity
Simpler Grants.gov #NOT-CA-25-042
NIH Forecasts Funding for NCORP Research Bases for Cancer Clinical Research
Buyer
National Institutes of Health
Posted
May 28, 2025
Respond By
November 14, 2025
Identifier
NOT-CA-25-042
NAICS
541715
The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is forecasting a funding opportunity for the NCI Community Oncology Research Program (NCORP) Research Bases. - Government Buyer: - National Institutes of Health (NIH), National Cancer Institute (NCI) - Scope of Work: - Establish and operate NCORP Research Bases as research hubs - Provide scientific and statistical leadership for multi-institutional cancer control, prevention, and care delivery clinical research - Oversee study operations, data management, protocol development, regulatory compliance, audits, training, and quality assurance - Support Community Sites, including those serving minority and underserved populations - Products/Services Requested: - Research base operations and leadership for cancer clinical research (no specific part numbers or OEMs) - Notable Requirements: - Research activities must include cancer control research - Optional research in cancer prevention and cancer care delivery - Support for quality-of-life studies embedded in treatment and imaging studies - Eligible applicants: government, nonprofit, educational, and business organizations - Funding Details: - Up to 7 awards anticipated - Total program funding of $60,000,000 - No specific OEMs or commercial vendors are named, as this is a grant opportunity for research organizations.
Description
This Notice of Funding Opportunity (NOFO) is for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Research Bases. NCORP aims to enhance the generalizability and dissemination of clinical trial results through accrual in community settings, focusing on cancer control, prevention, treatment, and care delivery. The Research Bases will serve as research hubs, providing leadership for multi-institutional cancer clinical research and managing study operations and data. The scope includes cancer control research (required), cancer prevention research, and cancer care delivery research (optional).